Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.62 and traded as low as $1.8389. Evotec shares last traded at $1.86, with a volume of 121,907 shares traded.
Evotec Stock Down 2.1%
The company has a market cap of $614.21 million, a P/E ratio of 4.54 and a beta of 0.98. The company has a 50 day moving average of $2.13 and a 200-day moving average of $2.61. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
See Also
- Five stocks we like better than Evotec
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
